Various oncogenes and tumor suppressors, such as KRAS, APC, BRAF, TP53, and SMAD4, have been identified by CRC‐related studies and may be useful for diagnosing and treating CRC in the future 10, 11. Here, TP53 is linked to colorectal carcinoma.